Lung Cancer Video Library Spanish - Raez - TERAPIA DIRIGIDA PARA CANCERES DE PULMON ntrk1 3
Para este año, además de nuestra videoteca de cáncer de pulmón producida en español para nuestra comunidad latina, el Dr. Luis Raez nos brinda información actualizada.
En este video, el Dr. Raez discute las terapias dirigidas para NSCLC (NTRK 1-3).
Para más información, visite http://cancerGRACE.org/. Para unirse a la conversación, visite https://cancergrace.org/forum.
*****
For this years addition to our Lung Cancer Video Library produced in Spanish for our Latino Community, Dr. Luis Raez provides us with up to date information.
In this video, Dr. Raez discusses targeted therapies for NSCLC (NTRK 1-3).
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
En este video, el Dr. Raez discute las terapias dirigidas para NSCLC (NTRK 1-3).
Para más información, visite http://cancerGRACE.org/. Para unirse a la conversación, visite https://cancergrace.org/forum.
*****
For this years addition to our Lung Cancer Video Library produced in Spanish for our Latino Community, Dr. Luis Raez provides us with up to date information.
In this video, Dr. Raez discusses targeted therapies for NSCLC (NTRK 1-3).
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.
Non-Small Cell Lung Cancer
EGFR TKIs and Their Side Effects - 2022 Program: Targeted Therapies Forum
What is EGFR in Lung Cancer? - 2022 Program: Targeted Therapies Forum
Do Side Effects of TKIs Decrease Over Time? - 2022 Program: Targeted Therapies Forum
Stage 4 ALK+ Disease: Development of L1196M on Loratinib - 2022 Program: Targeted Therapies Forum
EGFR+ and Pneumonitis: Treatments Other Than Erlotinib - 2022 Program: Targeted Therapies Forum
Lesion After Reduced Alectinib: Add Chemo and Pemetrexed? - 2022 Program: Targeted Therapies Forum
Developing Nodularities on Alectinib: Is It Pneumonitis? - 2022 Program: Targeted Therapies Forum
EGFR Mutated NSCLC Disease Progression on Osimertinib - 2022 Program: Targeted Therapies Forum
EGFR Mutated NSCLC with Brain Metastasis - 2022 Program: Targeted Therapies Forum
Oligoprogression with Non-EGFR Mutations - 2022 Program: Targeted Therapies Forum
Do Side Effects Signify Better Response to Treatment? - 2022 Program: Targeted Therapies Forum
Should we use DNA or RNA for NGS? - 2022 Program: Targeted Therapies Forum